Fri, August 4, 2023
Thu, August 3, 2023
Wed, August 2, 2023

Matthew Kaplan Maintained (UTHR) at Strong Buy with Increased Target to $268 on, Aug 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-268-on-aug-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Kaplan of Ladenburg Thalmann, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Increased Target from $256 to $268 on, Aug 3rd, 2023.

Matthew has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $280 on, Friday, April 21st, 2023
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $310 on, Monday, April 10th, 2023

Publication Contributing Sources